Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-01

FDA Approved: ROSUVASTATIN — Original Application (AiPing Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved AiPing Pharmaceutical, Inc.'s rosuvastatin as a generic product under an original application, enabling marketing of this statin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

ORIG AP for ROSUVASTATIN (ROSUVASTATIN)